"9th Annual Congress on Drug Formulation & Drug Design"

Conference object OPEN
Monty Karl (2017)
  • Related identifiers: doi: 10.2017/foo.bar'.
  • Subject: Drug Development, Drug Design ,Nano Particle
    mesheuropmc: education

Conference Series has been instrumental in conducting international meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Belgium, Tokyo, Madrid, with success the meetings again scheduled in three continents. It’s time to announce 9th Annual Congress on Drug Formulation & Drug Design October 19-21, 2017 Seoul, South Korea . Drug Formulation 2017 is a 3-day event offering the Exhibition, at venue to showcase the research and development on emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF ( student presentation), poster, e-poster presentations. This is an excellent platform to intensify collaborations for Professionals Scientific Experts and Industrial Delegates for Pharma field knowledge seekers. Global Pharmaceutical Industry in its operation and innovation activities is now facing serious challenges resulted by mega trends in healthcare paradigm. Korean R&D-based pharmaceutical companies have been involving in pioneering unmet medical needs areas investing over 65% to their annual net profit with the strong support from the Korean government. Modern pharmaceutical industry in Korea has 110 years of history initiating at the end of the 1800s, when a first modern pharmaceutical company began its operation. However, the South Korea region represents a significant growth opportunity for the Drug Formulation market during the forecast period of 2014 to 2019. Everyone interested in the future of emerging –drugs majorly in the field drug discovery, design, drug development, pharmacokinetic research, clinical pharmacology and new therapeutic drugs on recent developments in the field of generic drug research, current challenges and possibilities in modeling a new drug involving Drug Formulaton & Drug Design Reasearch Who to attend: CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic) Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs Regulatory and Clinical Scientists involved in Drug Development Researchers, Education providers in Clinical Pharmacy, Pharmacology and Toxicology Students and Postdoctoral Fellows in All Areas of The Pharmaceutical Sciences Government Agencies involved in Chemical Safety Assessment Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists. Molecular and Cellular Pharmacologistsc Why to attend?? Exchange ideas and network with leading pharmaceutical scientists and clinicians and presenting cutting-edge discoveries, research and new therapeutic drugs Obtain a global roundup of Pharmaceutical research capabilities and opportunities
Share - Bookmark

  • Download from
    ZENODO via ZENODO (Conference object, 2017)
  • Cite this publication